• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHL2100034 ABBV-744片 ABBV-744 Tablet Chemical Drugs(1) Import Drug Application 2021-02-03 AbbVie Inc. Abbvie Inc In Review 2021-02-03 view
JXHL2100037 Navitoclax片 navitoclax Tablet Chemical Drugs(1) Import Drug Application 2021-02-03 AbbVie Inc. Abbvie Inc In Review 2021-02-03 view
JXHL2100036 Navitoclax片 navitoclax Tablet Chemical Drugs(1) Import Drug Application 2021-02-03 AbbVie Inc. Abbvie Inc In Review 2021-02-03 view
JXHL2100035 ABBV-744片 ABBV-744 Tablet Chemical Drugs(1) Import Drug Application 2021-02-03 AbbVie Inc. Abbvie Inc In Review 2021-02-03 view
JXSB2000054 Risankizumab注射液(ABBV-066) risankizumab Injection Biological Products(2.2) Supplementary Application 2020-12-25 AbbVie Inc. Abbvie Inc In Review 2021-05-09 view
JXSB2000055 Risankizumab注射液(ABBV-066) risankizumab Injection Biological Products(2.2) Supplementary Application 2020-12-25 AbbVie Inc. Abbvie Inc In Review 2021-05-09 view
JXSL2000218 Risankizumab注射液(ABBV-066) risankizumab Injection Biological Products(2.2) Import Drug Application 2020-12-10 AbbVie Inc. Abbvie Inc In Review 2020-12-09 view
JXSL2000219 Risankizumab注射液(ABBV-066) risankizumab Injection Biological Products(2.2) Import Drug Application 2020-12-10 AbbVie Inc. Abbvie Inc In Review 2020-12-09 view
JXHL2000263 Upadacitinib片 upadacitinib Tablet Chemical Drugs(2.4) Import Drug Application 2020-09-23 AbbVie Inc. Abbvie Inc In Review 2020-09-22 view
JXHL2000262 Upadacitinib片 upadacitinib Tablet Chemical Drugs(2.4) Import Drug Application 2020-09-23 AbbVie Inc. Abbvie Inc In Review 2020-09-22 view
JXHL2000261 Elsubrutinib(ABBV-105)胶囊 elsubrutinib Capsule Chemical Drugs(1) Import Drug Application 2020-09-23 AbbVie Inc. Abbvie Inc In Review 2020-09-22 view
JXHB2000023 ABT-494片 upadacitinib Tablet Chemical Drugs(2.4) Supplementary Application 2020-09-04 AbbVie Inc. Abbvie Inc In Review 2020-09-03 view
JXHB2000022 ABT-494片 upadacitinib Tablet Chemical Drugs(2.4) Supplementary Application 2020-09-04 AbbVie Inc. Abbvie Inc In Review 2020-09-03 view
JYHB2001571 洛匹那韦/利托那韦口服溶液 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2020-08-25 AbbVie Inc Abbvie Inc Certificate Issued 2021-02-25 view
JXHL2000185 Venetoclax片 Venetoclax Tablet Chemical Drugs(2.4) Import Drug Application 2020-07-06 AbbVie Inc. Abbvie Inc In Review 2020-07-04 view
JXHL2000184 Venetoclax片 Venetoclax Tablet Chemical Drugs(2.4) Import Drug Application 2020-07-06 AbbVie Inc. Abbvie Inc In Review 2020-07-04 view
JXHL2000186 Venetoclax片 Venetoclax Tablet Chemical Drugs(2.4) Import Drug Application 2020-07-06 AbbVie Inc. Abbvie Inc In Review 2020-07-04 view
JYHB2000636 洛匹那韦/利托那韦口服溶液 lopinavir;ritonavir Oral solution Chemical Drugs Supplementary Application 2020-05-27 AbbVie Inc Abbvie Inc Filed 2020-06-09 view
JXHS2000002 维奈克拉片 Venetoclax Tablet Chemical Drugs(5.1) Import Drug Application 2020-01-13 AbbVie Inc. Abbvie Inc Certificate Issued 2020-12-08 view
JXHS2000004 维奈克拉片 Venetoclax Tablet Chemical Drugs(5.1) Import Drug Application 2020-01-13 AbbVie Inc. Abbvie Inc Certificate Issued 2020-12-08 view